StockNews.com Begins Coverage on NeuroMetrix (NASDAQ:NURO)

Equities researchers at StockNews.com started coverage on shares of NeuroMetrix (NASDAQ:NURO) in a research report issued on Friday. The firm set a “sell” rating on the medical device company’s stock.

NeuroMetrix Stock Performance

NURO opened at $4.41 on Friday. The stock has a market capitalization of $8.78 million, a P/E ratio of -0.71 and a beta of 2.26. The company’s 50-day simple moving average is $3.87 and its two-hundred day simple moving average is $3.79. NeuroMetrix has a 52-week low of $2.70 and a 52-week high of $11.55.

NeuroMetrix (NASDAQ:NURO) last posted its earnings results on Thursday, February 22nd. The medical device company reported ($1.43) earnings per share (EPS) for the quarter. The company had revenue of $1.32 million for the quarter. NeuroMetrix had a negative net margin of 110.64% and a negative return on equity of 31.31%.

Institutional Investors Weigh In On NeuroMetrix

An institutional investor recently bought a new position in NeuroMetrix stock. Cerity Partners LLC bought a new position in NeuroMetrix, Inc. (NASDAQ:NURO) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 30,000 shares of the medical device company’s stock, valued at approximately $108,000. Cerity Partners LLC owned approximately 2.80% of NeuroMetrix at the end of the most recent quarter. Hedge funds and other institutional investors own 19.40% of the company’s stock.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.